Approval · Notice of Compliance 9311 · 2008
INOMAX: Notice of Compliance 9311
Issued January 23, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9311
- Date
- January 23, 2008
- Company
- Ino TherapeuticsBridgewater, New Jersey, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the toxicology section of the product monograph
- Therapeutic class
- Pulmonary vasodilator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INOMAX | Not yet assigned | — |
Medicinal ingredients
- NITRIC OXIDE 100 PPM per CYLR
- NITRIC OXIDE 800 PPM per CYLR